Martel-Laferrière, Valérie http://orcid.org/0000-0001-7973-8582
Feaster, Daniel J.
Metsch, Lisa R.
Schackman, Bruce R.
Loignon, Christine
Nosyk, Bohdan
Tookes, Hansel
Behrends, Czarina N.
Arruda, Nelson
Adigun, Oluleye
Goyer, Marie-Eve
Kolber, Michael A.
Mary, Jean-Francois
Rodriguez, Allan E.
Yanez, Iveth G.
Pan, Yue
Khemiri, Rania
Gooden, Lauren
Sako, Aïssata
Bruneau, Julie
Funding for this research was provided by:
National Institute on Drug Abuse (5R01DA045713)
Article History
Received: 26 May 2021
Accepted: 5 February 2022
First Online: 23 April 2022
Change Date: 27 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-022-06724-9
Declarations
:
: This trial is conducted in compliance with the appropriate protocol, current Good Clinical Practice (GCP), the principles of the Declaration of Helsinki, and all other applicable regulatory requirements. Prior to study initiation, the protocol and the informed consent documents were reviewed and approved by the following Ethics Review Committee (ERC) or IRB: Columbia University Irving Medical Center, Université de Montréal, University of Miami, Université de Sherbrooke, Weill Cornell Medicine, and Simon Fraser University.
: The following statement is included in the informed consent form (supplementary file): “Your name or other information that might reveal who you are will not be given in any reports or writings that may result from this study.”
: JB and VML report receiving study drugs as Gilead Science donations for investigational use. VML reports receiving Gilead Science and Merck funding for research unrelated to this study. JB reports receiving monetary compensation from Gilead Sciences and Abbvie unrelated to this study until 2019. HT reports receiving Gilead Science funding for research unrelated to this study. MEG reports monetary compensations for conferences from Idivior and Gilead Science outside of the submitted work. All other authors have nothing to disclose.